₹244.83▲1.67%
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 6.15 % |
3 Month Return | -14.44 % |
1 Year Return | + 20.44 % |
Market Stats | |
Previous Close | ₹240.82 |
Open | ₹247.62 |
Volume | 27.91K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹296.32Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹296.32 Cr |
P/B Ratio | 2.42 |
EPS | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
Par Drugs & Chemicals Ltd | NA | ₹296.32 Cr | 168.88% | 0.50 | NA | NA |
Decipher Labs Ltd | NA | ₹17.18 Cr | -6.84% | 0.50 | -₹3 Cr | ₹45 Cr |
Syschem (India) Ltd | NA | ₹164.28 Cr | 90.19% | 0.58 | NA | NA |
Kopran Ltd | NA | ₹1,131.02 Cr | 120.9% | 0.54 | ₹27 Cr | ₹550 Cr |
Beryl Drugs Ltd | NA | ₹14.76 Cr | 80.9% | 0.69 | NA | NA |
Organisation | Par Drugs & Chemicals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Par Drugs & Chemicals Ltd
Par Drugs & Chemicals Ltd has seen an excellent gain of 29% in the last month, bringing the annual gain to a sharp 78%. The company's strong earnings performance may have repressed the P/E, but if it continues, existing shareholders can be optimistic about future share price direction.
Par Drugs & Chemicals Ltd Shows Strong Growth Potential - 05 Apr, 2024
Par Drugs & Chemicals Ltd has shown consistent growth in EPS, EBIT margins, and revenues. With insiders holding 78% of the company, it's a stock worth following for potential investment opportunities.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 32.5%
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 66.7%
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.07% of holdings in Mar 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 74.21% of holdings in Mar 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 25.73% to 25.68% in Mar 2024 quarter
Price Dip
In the last 3 months, PAR stock has moved down by -14.4%
2023 | Y/Y Change | |
---|---|---|
Total Assets | ₹88.94Cr | ↑12.85% |
Total Liabilities | ₹17.71Cr | ↓6.49% |
2023 | Y/Y Change | |
---|---|---|
Operating Cash Flow | ₹13.38Cr | ↑75.59% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 74.21% | 0.00 | |
Foreign Institutions | 0.07% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 25.68% | 0.00 | |
Others | 0.05% | 0.00 |
Par Drugs & Chemicals Ltd’s net profit jumped 7.83% since last year same period to ₹3.72Cr in the Q4 2023-2024. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 8.77% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2021, Par Drugs & Chemicals Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.51%.
Read More about DividendsBearish
Neutral
Bullish
Par Drugs & Chemicals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Par Drugs & Chemicals Ltd (PAR) share price today is ₹244.83
Par Drugs & Chemicals Ltd is listed on NSE
Par Drugs & Chemicals Ltd is not listed on BSE
Today’s traded volume of Par Drugs & Chemicals Ltd(PAR) is 27.91K.
Today’s market capitalisation of Par Drugs & Chemicals Ltd(PAR) is ₹296.32Cr.
Par Drugs & Chemicals Ltd(PAR | Price |
---|---|
52 Week High | ₹325 |
52 Week Low | ₹178 |
Par Drugs & Chemicals Ltd(PAR) share price is ₹244.83. It is down -24.67% from its 52 Week High price of ₹325
Par Drugs & Chemicals Ltd(PAR) share price is ₹244.83. It is up 37.54% from its 52 Week Low price of ₹178
Par Drugs & Chemicals Ltd(PAR | Returns |
---|---|
1 Day Returns | 4.01% |
1 Month Returns | 6.15% |
3 Month Returns | -14.44% |
1 Year Returns | 20.44% |